Fetal Pain: Neurobiology, Clinical Practice, and Compassionate Care—A Narrative Review
- 1Department of Obstetrics and Gynecology, Lis Hospital for Women’s Health, Tel Aviv Sourasky University Medical Center (Ichilov), Tel Aviv, Israel (affiliated to the Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel)
- 2Department of Obstetrics and Gynecology, Rambam Health Care Campus, Haifa, Israel
- 3The Ruth and Bruce Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel
Abstract
Background: Whether a fetus can experience pain remains scientifically and clinically contested, particularly as invasive fetal procedures become more common.
Objectives: To review fetal nociceptive development, the evidence and uncertainties relevant to pain perception, and the clinical rationale for fetal analgesia during invasive procedures.
Methods: We performed a targeted narrative search of PubMed/MEDLINE, Google Scholar, the Cochrane Library, reference lists, and professional society websites. The final synthesis comprised 34 core sources.
Results: Functional nociceptive and neuroendocrine responses to noxious stimuli are documented from the mid-second trimester and can be attenuated by fetal opioids. Early thalamic and subplate circuitry may challenge the claim that mature cortical architecture is required for all pain-related processing, but this circuitry has not been shown to be sufficient for conscious pain. Continuous endogenous fetal sedation is not supported by behavioral evidence, although the fetal neurochemical environment may modulate arousal and sensory processing. Maternal anesthesia, especially regional anesthesia, may not provide reliable fetal analgesic exposure. Professional guidance differs on the gestational age at which pain perception becomes possible.
Conclusions: The clinical case for fetal analgesia should be separated from the unresolved question of conscious pain. Potential rationales include preventing possible suffering, attenuating documented physiological stress responses, and facilitating procedural stability. Decisions should therefore be based on a proportionate, procedure-specific maternal-fetal risk-benefit assessment rather than a universal precautionary default.
Related
- Decision-Supported Collaborative Care for Gestational Diabetes: A Narrative Review of Development Pathways and Evaluation in Routine Clinical Practice.
- Phenomenology and the ethics of dying: reclaiming the lived meaning of death in contemporary clinical practice in South Asia - a narrative review.
- Nursing leadership for sustainable endoscopy: a narrative review and practice framework
- Narrowing the research to practice gap for trauma-focused psychotherapies in the Veterans Health Administration: A narrative review
- Comparative and synergistic effects of digital devices and Child Life services in pediatric clinical practice: a systematic review
BibTeX
@article{dominsky2026fetal,
title = {{Fetal Pain: Neurobiology, Clinical Practice, and Compassionate Care—A Narrative Review}},
author = {Omri Dominsky and Ido Solt},
journal = {Rambam Maimonides Medical Journal},
year = {2026},
month = oct,
doi = {10.5041/rmmj.10583},
url = {https://doi.org/10.5041/rmmj.10583},
note = {CC BY 3.0},
}
RIS
TY - JOUR
TI - Fetal Pain: Neurobiology, Clinical Practice, and Compassionate Care—A Narrative Review
AU - Omri Dominsky
AU - Ido Solt
PY - 2026
DA - 2026/10/26
JO - Rambam Maimonides Medical Journal
DO - 10.5041/rmmj.10583
UR - https://doi.org/10.5041/rmmj.10583
AB - Background: Whether a fetus can experience pain remains scientifically and clinically contested, particularly as invasive fetal procedures become more common. Objectives: To review fetal nociceptive development, the evidence and uncertainties relevant to pain perception, and the clinical rationale for fetal analgesia during invasive procedures. Methods: We performed a targeted narrative search of PubMed/MEDLINE, Google Scholar, the Cochrane Library, reference lists, and professional society websites. The final synthesis comprised 34 core sources. Results: Functional nociceptive and neuroendocrine responses to noxious stimuli are documented from the mid-second trimester and can be attenuated by fetal opioids. Early thalamic and subplate circuitry may challenge the claim that mature cortical architecture is required for all pain-related processing, but this circuitry has not been shown to be sufficient for conscious pain. Continuous endogenous fetal sedation is not supported by behavioral evidence, although the fetal neurochemical environment may modulate arousal and sensory processing. Maternal anesthesia, especially regional anesthesia, may not provide reliable fetal analgesic exposure. Professional guidance differs on the gestational age at which pain perception becomes possible. Conclusions: The clinical case for fetal analgesia should be separated from the unresolved question of conscious pain. Potential rationales include preventing possible suffering, attenuating documented physiological stress responses, and facilitating procedural stability. Decisions should therefore be based on a proportionate, procedure-specific maternal-fetal risk-benefit assessment rather than a universal precautionary default.
SN - 2076-9172
ER -